Nasdaq:US$14.01 (+1.61) | HKEX:HK$21.60 (+1.00) | AIM:£2.36 (+0.25)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729